Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Filings indexed 1,267 across all filing types
Latest filing 2020-08-10 Regulatory Filings
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2020-08-10 English
The Board of Directors of the Company at their meeting held today i.e, August 10, 2020, has inter-alia: 1. Approved the Unaudited Financial Results of the Company for the quarter ....
Regulatory Filings
2020-08-10 English
We are enclosing herewith Certificate dated August 4, 2020 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings Classification · 95% confidence The document is a certificate issued pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming compliance. It is addressed to stock exchanges and signed by the company secretary. The document length is short (1505 characters) and it primarily serves as a compliance certificate rather than a full report or financial statement. It does not contain financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which covers compliance documents and certifications that do not fit other categories.
2020-08-04 English
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing a copy of newspaper advertisement published in ''Business Standard'' ....
Regulatory Filings Classification · 90% confidence The document contains only placeholders for images and no textual content or financial data. It is extremely short (110 characters) and does not provide any report, announcement, or regulatory information. Given the lack of content, it does not fit any specific filing category and defaults to Regulatory Filings (RNS) as a fallback category.
2020-08-04 English
Updates
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agents of the company. It is addressed to stock exchanges and confirms compliance with a specific regulatory requirement. The document is short (1505 characters) and does not contain any financial data, management discussion, or detailed report content. It is essentially a regulatory compliance certificate, not a financial report or announcement of voting results, dividends, or capital changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance certificates and miscellaneous regulatory documents.
2020-08-04 English
Copy of Newspaper Publication
Regulatory Filings Classification · 90% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 110 characters, indicating it is extremely short and does not contain any report content. There is no indication of any report, announcement, or filing type. Given the lack of content, the document cannot be classified as a report or announcement but fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without substantive content.
2020-08-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.